Eli Lilly: sues US federal agency

(CercleFinance.com) - Eli Lilly has sued the HRSA (a US federal agency under the Department of Health and Human Services) for rejecting its plan to modify the 340B program, aimed at offering reduced prices on its drugs via a more efficient cash replenishment model, in partnership with Kalderos.


According to Eli Lilly, the current program is 'indirect and slow' and 'open to abuse'.

On the other hand, the laboratory asserts that its model guarantees prompt payments directly to covered entities, ensuring compliance with existing laws and the new requirements of the Inflation Reduction Act.

The laboratory is therefore contesting the HRSA's rejection, which it regards as 'arbitrary', believing that it does not have the authority to do so. Eli Lilly is therefore preparing to defend its position in court.


Copyright (c) 2024 CercleFinance.com. All rights reserved.